ClinicalTrials.gov
ClinicalTrials.gov Menu

Closed Versus Open Cells Stent for Acute Myocardial Infarction (COCHISE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01152138
Recruitment Status : Completed
First Posted : June 29, 2010
Last Update Posted : May 17, 2012
Sponsor:
Information provided by (Responsible Party):
Alessandro Sciahbasi, Policlinico Casilino ASL RMB

Brief Summary:
The aim of this study is to determine whether a closed cell stent design may reduce distal embolization and no reflow during primary percutaneous coronary intervention (PPCI) for acute ST-elevation acute myocardial infarction (STEMI) compared to an open cell stent design. The study population will include all consecutive patients admitted for acute STEMI and treated with PPCI within 12 hours from symptom onset.

Condition or disease Intervention/treatment Phase
Acute Myocardial Infarction Primary Percutaneous Coronary Intervention Device: Open cells stent Device: Closed Cells Stent Not Applicable

  Show Detailed Description

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 223 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: COCHISE Pilot Study: Closed vs Open Cells Stent for High Risk Percutaneous Coronary Interventions in ST Elevation Acute Myocardial Infarction
Study Start Date : March 2010
Actual Primary Completion Date : December 2011
Actual Study Completion Date : December 2011

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Attack

Arm Intervention/treatment
Active Comparator: Open Cell Stent
Open cell stent (Driver™ or Integrity™,Medtronic), routinely employed during percutaneous coronary interventions for ST elevation acute myocardial infarction
Device: Open cells stent
Cobalt Chromium Stent with open cell design
Other Names:
  • Driver Stent, Medtronic
  • Integrity Stent, Medtronic

Active Comparator: Closed Cell Stent
Closed cell stent (Presillion Plus™, Cordis), routinely employed during percutaneous coronary interventions for ST elevation acute myocardial infarction
Device: Closed Cells Stent
Cobalt Chromium stent with closed cell design
Other Name: Presillion Plus Stent, Cordis




Primary Outcome Measures :
  1. Post procedural angiographic evaluation [ Time Frame: whithin 1 day ]
    The corrected Thrombolysis In Myocardial Infarction (TIMI) frame count at the end of the procedure defined as the number of frames required to opacify angiographic landmarks and normalized for vessel length and a composite end-point including angiographic events such as distal embolization, slow-flow (decrease in flow from TIMI 3 to TIMI 2) or no-reflow (decrease from TIMI 2 or 3 to TIMI 0 or 1) and a binary electrocardiographic criterion of microvascular injury as defined by the presence of persistent (>50% of initial value) ST-segment elevation 30-60 min after procedure


Secondary Outcome Measures :
  1. Post stent angiographic results and in hospital MACE [ Time Frame: whithin 7 days ]
    The corrected Thrombolysis In Myocardial Infarction (TIMI) frame count after stent deployment; a composite angiographic end-point including angiographic events such as distal embolization, slow-flow (decrease in flow from TIMI 3 to TIMI 2) or no-reflow (decrease in flow from TIMI 2 or 3 to TIMI 0 or 1) after stent deployment; the infarct size detect by myocardial enzyme release, in hospital major adverse cardac events (MACE)(death, reinfarction, target lesion revascularization)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • patients with an age > 18 years with acute ST elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PPCI) within 12 hours from symptom onset and who agree and provide written informed consent. STEMI is defined as chest pain associated with ST-elevation of 1 mm or more in two or more contiguous leads or new left bundle-branch block within 12 hours after the onset of chest pain

Exclusion Criteria:

  • implanted stent with diameter < 2.5 mm
  • cardiogenic shock
  • time from pain onset to PPCI >12 hours
  • previous thrombolytic therapy (rescue PPCI)
  • inability to provide informed consent.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01152138


Locations
Italy
UOC Cardiologia - Policlinico Casilino - ASL RMB
Rome, Italy
UOC Cardiologia - Ospedale Belcolle
Viterbo, Italy
Sponsors and Collaborators
Alessandro Sciahbasi
Investigators
Principal Investigator: Alessandro Sciahbasi, MD Policilnico Casilino - ASL RMB

Responsible Party: Alessandro Sciahbasi, Medical doctor, Policlinico Casilino ASL RMB
ClinicalTrials.gov Identifier: NCT01152138     History of Changes
Other Study ID Numbers: COCHISE
First Posted: June 29, 2010    Key Record Dates
Last Update Posted: May 17, 2012
Last Verified: May 2012

Keywords provided by Alessandro Sciahbasi, Policlinico Casilino ASL RMB:
Acute myocardial infarction
Closed cell stent
Open cell stent
primary percutaneous coronary intervention

Additional relevant MeSH terms:
Infarction
Myocardial Infarction
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases